Literature DB >> 12269551

Autonomic dysfunction in Wilson's disease --a clinical and electrophysiological study.

Salvadeeswaran Meenakshi-Sundaram1, Arun B Taly, Vikram Kamath, G R Arunodaya, Shivaji Rao, H S Swamy.   

Abstract

Wilson's disease is known for its protean manifestations; however involvement of the autonomic nervous system has not received much attention. Fifty patients with varying duration and severity of illness were evaluated for autonomic dysfunction clinically and electrophysiologically, using sympathetic skin response (SSR) and RR interval variability (RRIV) on deep breathing. The change in heart rate (AHR) was calculated from RRIV. Five patients had at least one autonomic symptom and one asymptomatic patient had significant postural hypotension. Absent SSR and abnormal AHR were noted in seven patients each. Overall, 13 patients had electrophysiological dysautonomia and an additional six had clinical dysautonomia. All had normal peripheral conductions and all but one had normal hepatic functions. Dysautonomia was more common among patients with neurological presentation (12/32) than non-neurological (1/18) (p = .012). Dysautonomia, often subclinical is common in Wilson's disease and is probably of central origin. It is more frequent among those with neurological presentation. Sympathetic and parasympathetic functions are equally affected.

Entities:  

Mesh:

Year:  2002        PMID: 12269551     DOI: 10.1007/s10286-002-0038-6

Source DB:  PubMed          Journal:  Clin Auton Res        ISSN: 0959-9851            Impact factor:   4.435


  15 in total

1.  Wilson's disease: cranial MRI observations and clinical correlation.

Authors:  S Sinha; A B Taly; S Ravishankar; L K Prashanth; K S Venugopal; G R Arunodaya; M K Vasudev; H S Swamy
Journal:  Neuroradiology       Date:  2006-06-03       Impact factor: 2.804

2.  Improvement of cardiovascular autonomic dysfunction following anti-copper therapy in Wilson's disease.

Authors:  Kazushi Deguchi; Iwao Sasaki; Tetsuo Touge; Masago Tsukaguchi; Kazuyo Ikeda; Mieko Shimamura; Yoshiteru Urai; Seishiro Watanabe; Hiroaki Takeuchi; Shigeki Kuriyama
Journal:  J Neurol       Date:  2005-02-23       Impact factor: 4.849

3.  P wave dispersion is prolonged in patients with Wilson's disease.

Authors:  Nurcan Arat; Sabite Kacar; Zehra Golbasi; Meral Akdogan; Yeliz Sokmen; Sedef Kuran; Ramazan Idilman
Journal:  World J Gastroenterol       Date:  2008-02-28       Impact factor: 5.742

Review 4.  Clinical manifestations of Wilson disease in organs other than the liver and brain.

Authors:  Karolina Dzieżyc-Jaworska; Tomasz Litwin; Anna Członkowska
Journal:  Ann Transl Med       Date:  2019-04

Review 5.  Challenges in the diagnosis of Wilson disease.

Authors:  Aurélia Poujois; France Woimant
Journal:  Ann Transl Med       Date:  2019-04

Review 6.  Neurologic impairment in Wilson disease.

Authors:  Petr Dusek; Tomasz Litwin; Anna Członkowska
Journal:  Ann Transl Med       Date:  2019-04

7.  Improvement of Diffusion Tensor Imaging (DTI) Parameters with Decoppering Treatment in Wilson's Disease.

Authors:  A Lawrence; J Saini; S Sinha; S Rao; M Naggappa; P S Bindu; A B Taly
Journal:  JIMD Rep       Date:  2015-06-30

8.  Do cytokines have any role in Wilson's disease?

Authors:  M K Goyal; S Sinha; S A Patil; V Jayalekshmy; A B Taly
Journal:  Clin Exp Immunol       Date:  2008-10       Impact factor: 4.330

9.  Diffusion tensor imaging (DTI) and its clinical correlates in drug naïve Wilson's disease.

Authors:  Rakesh Jadav; Jitender Saini; Sanjib Sinha; Bhavanishankara Bagepally; S Rao; Arun B Taly
Journal:  Metab Brain Dis       Date:  2013-05-01       Impact factor: 3.584

10.  Structural and Functional Changes Are Related to Cognitive Status in Wilson's Disease.

Authors:  Sheng Hu; Chunsheng Xu; Ting Dong; Hongli Wu; Yi Wang; Anqin Wang; Hongxing Kan; Chuanfu Li
Journal:  Front Hum Neurosci       Date:  2021-02-25       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.